Evaxion to present at world vaccine congress

Copenhagen, denmark, april 10, 2025 - evaxion biotech a/s (nasdaq: evax) (“evaxion”), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, will give two presentations and man a booth at the world vaccine congress taking place april 21-24, 2025, in washington, d.c.

EVAX Ratings Summary

EVAX Quant Ranking